SPINRAZA 28 mg
Sponsors
Biogen Idec Research Limited
Conditions
Spinal Muscular Atrophy
Phase 3
A Phase 3b Study to Evaluate Higher Dose Nusinersen (BIIB058) in Patients with Spinal Muscular Atrophy Previously Treated with Risdiplam - ASCEND
Active, not recruitingCTIS2023-505639-11-00
Start: 2022-09-14Target: 22Updated: 2026-01-22
A Long-Term Extension Study of Nusinersen (BIIB058) Administered at Higher Doses in Participants With Spinal Muscular Atrophy Who Previously Participated in an Investigational Study With Nusinersen - ONWARD
Active, not recruitingCTIS2023-505637-27-00
Start: 2021-07-12Target: 26Updated: 2026-01-26